Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 15
Submit an article Journal homepage
1,011
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase

Kohei KakuKawasaki Medical School, 577, Matsushima, Kurashiki-shi, Okayama 701-0192, Japan+81 86 462 1111; +81 86 462 1199; [email protected]
,
Mikiko MoriTakeda Pharmaceutical Company Limited, Osaka, Japan
,
Tatsuhiro KanooTakeda Pharmaceutical Company Limited, Osaka, Japan
,
Masafumi KatouTakeda Pharmaceutical Company Limited, Osaka, Japan
&
Yutaka SeinoKansai Electric Power Hospital, Osaka, Japan
Pages 2121-2130 | Published online: 05 Sep 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.